WDR4 promotes tumor cells metastasis and resistance to sorafenib via epithelial-mesenchymal transition (EMT), thereby promoting the proliferation of hepatocellular carcinoma cells (27). This evidence concerns the gene WDR4 and hepatocellular carcinoma.